Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 5 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 17, 2026 22:15 UTC |
Gentile KimberlySVP, Clinical Operations
|
GrantStock Options (Right to buy) · Derivative | 1,000 | $0.00 Strike: $12.34 | $0.00 |
DisclosureSEC source: 0001704186-26-000006 · wk-form4_1789683308.xml · derivative · entry 1 Gentile Kimberly · CIK 0001704186 · SVP, Clinical Operations 10b5-1 filing: No plan indicated Ownership: Indirect · By Son Disclosed balance after: 1,000 Underlying: Common Shares · 1,000 shares Expires 2036-09-15 F1 · derivative.exercise_date: The shares underlying this option vest in four equal installments on September 15, 2026, 2027, 2028 and 2029, subject to the Reporting Person's son's continuous service with the Issuer at each vesting date. F2 · balance_after: Represents a stock option granted to the Reporting Person's son in connection with the commencement of his employment with the Issuer. The Reporting Person disclaims beneficial ownership of all securities held by her son, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| April 28, 2026 Filed May 1, 2026 00:07 UTC |
CHILDS JOHN WDirector
|
GrantStock Options (Right to buy) · Derivative | 68,693 | $0.00 Strike: $9.61 | $0.00 |
DisclosureSEC source: 0001027035-26-000008 · wk-form4_1777594070.xml · derivative · entry 1 CHILDS JOHN W · CIK 0001027035 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,693 Underlying: Common Shares · 68,693 shares Expires 2036-04-28 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| April 28, 2026 Filed May 1, 2026 00:09 UTC |
Bailey GregoryDirector
|
GrantStock Options (Right to buy) · Derivative | 68,693 | $0.00 Strike: $9.61 | $0.00 |
DisclosureSEC source: 0001329505-26-000005 · wk-form4_1777594149.xml · derivative · entry 1 Bailey Gregory · CIK 0001329505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,693 Underlying: Common Shares · 68,693 shares Expires 2036-04-28 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| April 28, 2026 Filed May 1, 2026 00:09 UTC |
Mehta KishanDirector
|
GrantStock Options (Right to buy) · Derivative | 68,693 | $0.00 Strike: $9.61 | $0.00 |
DisclosureSEC source: 0001850520-26-000005 · wk-form4_1777594180.xml · derivative · entry 1 Mehta Kishan · CIK 0001850520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,693 Underlying: Common Shares · 68,693 shares Expires 2036-04-28 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| April 28, 2026 Filed May 1, 2026 00:08 UTC |
Heffernan Michael ThomasDirector
|
GrantStock Options (Right to buy) · Derivative | 68,693 | $0.00 Strike: $9.61 | $0.00 |
DisclosureSEC source: 0001448914-26-000002 · wk-form4_1777594127.xml · derivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,693 Underlying: Common Shares · 68,693 shares Expires 2036-04-28 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| April 28, 2026 Filed May 1, 2026 00:08 UTC |
Antonijevic IrinaDirector
|
GrantStock Options (Right to buy) · Derivative | 68,693 | $0.00 Strike: $9.61 | $0.00 |
DisclosureSEC source: 0001926476-26-000002 · wk-form4_1777594081.xml · derivative · entry 1 Antonijevic Irina · CIK 0001926476 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,693 Underlying: Common Shares · 68,693 shares Expires 2036-04-28 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| April 28, 2026 Filed May 1, 2026 00:07 UTC |
HUGIN ROBERT JDirector
|
GrantStock Options (Right to buy) · Derivative | 68,693 | $0.00 Strike: $9.61 | $0.00 |
DisclosureSEC source: 0001232505-26-000003 · wk-form4_1777594053.xml · derivative · entry 1 HUGIN ROBERT J · CIK 0001232505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,693 Underlying: Common Shares · 68,693 shares Expires 2036-04-28 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| April 28, 2026 Filed May 1, 2026 00:06 UTC |
GREGORY JULIA PDirector
|
GrantStock Options (Right to buy) · Derivative | 68,693 | $0.00 Strike: $9.61 | $0.00 |
DisclosureSEC source: 0001226675-26-000002 · wk-form4_1777593998.xml · derivative · entry 1 GREGORY JULIA P · CIK 0001226675 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,693 Underlying: Common Shares · 68,693 shares Expires 2036-04-28 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 22:17 UTC |
Mehta KishanDirector
|
GiftCommon Shares | 17,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001850520-26-000003 · wk-form4_1773958666.xml · nonDerivative · entry 2 Mehta Kishan · CIK 0001850520 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Kishen Mehta 21 Family Irrevocable Trust Disclosed balance after: 17,342 F1 · ownership.nature: These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse and the spouse's sibling are co-trustees of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 22:17 UTC |
Mehta KishanDirector
|
GiftCommon Shares | 17,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001850520-26-000003 · wk-form4_1773958666.xml · nonDerivative · entry 1 Mehta Kishan · CIK 0001850520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,320 Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 18:09 UTC |
Buten MatthewChief Financial Officer
|
GrantStock Options (Right to buy) · Derivative | 175,000 | $0.00 Strike: $11.52 | $0.00 |
DisclosureSEC source: 0001898799-26-000004 · wk-form4_1772579341.xml · derivative · entry 1 Buten Matthew · CIK 0001898799 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Shares · 175,000 shares Expires 2036-02-27 F1 · derivative.exercise_date: The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:08 UTC |
Gentile KimberlySVP, Clinical Operations
|
GrantStock Options (Right to buy) · Derivative | 175,000 | $0.00 Strike: $11.52 | $0.00 |
DisclosureSEC source: 0001704186-26-000004 · wk-form4_1772579294.xml · derivative · entry 1 Gentile Kimberly · CIK 0001704186 · SVP, Clinical Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Shares · 175,000 shares Expires 2036-02-27 F1 · derivative.exercise_date: The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:08 UTC |
Clark George C.VP, Chief Accounting Officer
|
GrantStock Options (Right to buy) · Derivative | 50,000 | $0.00 Strike: $11.52 | $0.00 |
DisclosureSEC source: 0001878290-26-000004 · wk-form4_1772579282.xml · derivative · entry 1 Clark George C. · CIK 0001878290 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2036-02-27 F1 · derivative.exercise_date: The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:07 UTC |
Car BruceChief Scientific Officer
|
GrantStock Options (Right to buy) · Derivative | 175,000 | $0.00 Strike: $11.52 | $0.00 |
DisclosureSEC source: 0001798876-26-000004 · wk-form4_1772579259.xml · derivative · entry 1 Car Bruce · CIK 0001798876 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Shares · 175,000 shares Expires 2036-02-27 F1 · derivative.exercise_date: The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:04 UTC |
Coric VladDirector · Chief Executive Officer
|
GrantStock Options (Right to buy) · Derivative | 550,000 | $0.00 Strike: $11.52 | $0.00 |
DisclosureSEC source: 0001704317-26-000004 · wk-form4_1772579067.xml · derivative · entry 1 Coric Vlad · CIK 0001704317 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 550,000 Underlying: Common Shares · 550,000 shares Expires 2036-02-27 F1 · derivative.exercise_date: The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:33 UTC |
Buten MatthewChief Financial Officer
|
Exercise / conversionRestricted Share Unit Award · Derivative | 4,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001898799-26-000002 · wk-form4_1767839598.xml · derivative · entry 3 Buten Matthew · CIK 0001898799 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Shares · 4,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F3 · price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted 17,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date. F5 · derivative.expiration_date: Not applicable. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:33 UTC |
Buten MatthewChief Financial Officer
|
Tax withholdingCommon Shares | 2,594 | $9.93 | $25,758.42 |
DisclosureSEC source: 0001898799-26-000002 · wk-form4_1767839598.xml · nonDerivative · entry 2 Buten Matthew · CIK 0001898799 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,652 F2 · shares: No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units. F1 · balance_after: This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:33 UTC |
Buten MatthewChief Financial Officer
|
Exercise / conversionCommon Shares | 4,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001898799-26-000002 · wk-form4_1767839598.xml · nonDerivative · entry 1 Buten Matthew · CIK 0001898799 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:34 UTC |
Gentile KimberlySVP, Clinical Operations
|
Exercise / conversionRestricted Share Unit Award · Derivative | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001704186-26-000002 · wk-form4_1767839645.xml · derivative · entry 3 Gentile Kimberly · CIK 0001704186 · SVP, Clinical Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Shares · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F2 · price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted 15,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:34 UTC |
Gentile KimberlySVP, Clinical Operations
|
Tax withholdingCommon Shares | 1,956 | $9.93 | $19,423.08 |
DisclosureSEC source: 0001704186-26-000002 · wk-form4_1767839645.xml · nonDerivative · entry 2 Gentile Kimberly · CIK 0001704186 · SVP, Clinical Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,557 F1 · shares: No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:34 UTC |
Gentile KimberlySVP, Clinical Operations
|
Exercise / conversionCommon Shares | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001704186-26-000002 · wk-form4_1767839645.xml · nonDerivative · entry 1 Gentile Kimberly · CIK 0001704186 · SVP, Clinical Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:32 UTC |
Car BruceChief Scientific Officer
|
Exercise / conversionRestricted Share Unit Award · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001798876-26-000002 · wk-form4_1767839521.xml · derivative · entry 4 Car Bruce · CIK 0001798876 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Shares · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F3 · price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted 19,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date. F5 · derivative.expiration_date: Not applicable. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:32 UTC |
Car BruceChief Scientific Officer
|
Tax withholdingCommon Shares | 2,381 | $9.93 | $23,643.33 |
DisclosureSEC source: 0001798876-26-000002 · wk-form4_1767839521.xml · nonDerivative · entry 2 Car Bruce · CIK 0001798876 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,715 F2 · shares: No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units. F1 · balance_after: This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:32 UTC |
Car BruceChief Scientific Officer
|
Exercise / conversionCommon Shares | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001798876-26-000002 · wk-form4_1767839521.xml · nonDerivative · entry 1 Car Bruce · CIK 0001798876 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:32 UTC |
Coric VladDirector · Chief Executive Officer
|
Exercise / conversionRestricted Share Unit Award · Derivative | 14,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001704317-26-000002 · wk-form4_1767839548.xml · derivative · entry 6 Coric Vlad · CIK 0001704317 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Shares · 14,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F3 · price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted 57,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date. F5 · derivative.expiration_date: Not applicable. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:32 UTC |
Coric VladDirector · Chief Executive Officer
|
Tax withholdingCommon Shares | 7,430 | $9.93 | $73,779.90 |
DisclosureSEC source: 0001704317-26-000002 · wk-form4_1767839548.xml · nonDerivative · entry 2 Coric Vlad · CIK 0001704317 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,803,968 F1 · shares: No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:32 UTC |
Coric VladDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 14,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001704317-26-000002 · wk-form4_1767839548.xml · nonDerivative · entry 1 Coric Vlad · CIK 0001704317 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,811,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:31 UTC |
Clark George C.VP, Chief Accounting Officer
|
Exercise / conversionRestricted Share Unit Award · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001878290-26-000002 · wk-form4_1767839475.xml · derivative · entry 4 Clark George C. · CIK 0001878290 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Shares · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F2 · price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted 10,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:31 UTC |
Clark George C.VP, Chief Accounting Officer
|
Tax withholdingCommon Shares | 1,117 | $9.93 | $11,091.81 |
DisclosureSEC source: 0001878290-26-000002 · wk-form4_1767839475.xml · nonDerivative · entry 2 Clark George C. · CIK 0001878290 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,978 F1 · shares: No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units. Read SEC document |
| January 05, 2026 Filed Jan 8, 2026 02:31 UTC |
Clark George C.VP, Chief Accounting Officer
|
Exercise / conversionCommon Shares | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001878290-26-000002 · wk-form4_1767839475.xml · nonDerivative · entry 1 Clark George C. · CIK 0001878290 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 12:29 UTC |
Clark George C.VP, Chief Accounting Officer
|
PurchaseCommon Shares | 17,000 | $8.52 | $144,770.30 |
DisclosureSEC source: 0001878290-25-000004 · wk-form4_1763468947.xml · nonDerivative · entry 1 Clark George C. · CIK 0001878290 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By IRA Disclosed balance after: 20,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4950 - $8.5200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 12:30 UTC |
CHILDS JOHN WDirector
|
PurchaseCommon Shares | 3,333,333 | $7.50 | $24,999,997.50 |
DisclosureSEC source: 0001027035-25-000004 · wk-form4_1763382643.xml · nonDerivative · entry 1 CHILDS JOHN W · CIK 0001027035 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By John W Childs 2013 Revocable Trust Disclosed balance after: 5,653,904 F1 · shares: Represents common shares acquired in an underwritten public offering. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 12:31 UTC |
Bailey GregoryDirector
|
PurchaseCommon Shares | 400,000 | $7.50 | $3,000,000.00 |
DisclosureSEC source: 0001935979-25-000096 · wk-form4_1763382679.xml · nonDerivative · entry 1 Bailey Gregory · CIK 0001329505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,020,071 F1 · shares: Represents common shares acquired in an underwritten public offering. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 12:30 UTC |
Coric VladDirector · Chief Executive Officer
|
PurchaseCommon Shares | 333,333 | $7.50 | $2,499,997.50 |
DisclosureSEC source: 0001704317-25-000004 · wk-form4_1763382609.xml · nonDerivative · entry 2 Coric Vlad · CIK 0001704317 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By: The Vladimir Coric Marital Trust Disclosed balance after: 740,546 F1 · shares: Represents common shares acquired in an underwritten public offering. F2 · ownership.nature: These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 13, 2025 Filed Nov 17, 2025 12:30 UTC |
Coric VladDirector · Chief Executive Officer
|
PurchaseCommon Shares | 333,333 | $7.50 | $2,499,997.50 |
DisclosureSEC source: 0001704317-25-000004 · wk-form4_1763382609.xml · nonDerivative · entry 1 Coric Vlad · CIK 0001704317 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By: The Vlad Coric Family Trust Disclosed balance after: 1,195,275 F1 · shares: Represents common shares acquired in an underwritten public offering. F2 · ownership.nature: These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| May 05, 2025 Filed May 7, 2025 21:12 UTC |
CHILDS JOHN WDirector
|
GrantStock Options (Right to buy) · Derivative | 31,716 | $0.00 Strike: $22.62 | $0.00 |
DisclosureSEC source: 0001935979-25-000042 · wk-form4_1746652349.xml · derivative · entry 1 CHILDS JOHN W · CIK 0001027035 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,716 Underlying: Common Shares · 31,716 shares Expires 2035-05-05 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| May 05, 2025 Filed May 7, 2025 21:15 UTC |
Heffernan Michael ThomasDirector
|
GrantStock Options (Right to buy) · Derivative | 31,716 | $0.00 Strike: $22.62 | $0.00 |
DisclosureSEC source: 0001935979-25-000046 · wk-form4_1746652496.xml · derivative · entry 1 Heffernan Michael Thomas · CIK 0001448914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,716 Underlying: Common Shares · 31,716 shares Expires 2035-05-05 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| May 05, 2025 Filed May 7, 2025 21:16 UTC |
Antonijevic IrinaDirector
|
GrantStock Options (Right to buy) · Derivative | 31,716 | $0.00 Strike: $22.62 | $0.00 |
DisclosureSEC source: 0001935979-25-000048 · wk-form4_1746652555.xml · derivative · entry 1 Antonijevic Irina · CIK 0001926476 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,716 Underlying: Common Shares · 31,716 shares Expires 2035-05-05 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| May 05, 2025 Filed May 7, 2025 21:14 UTC |
Bailey GregoryDirector
|
GrantStock Options (Right to buy) · Derivative | 31,716 | $0.00 Strike: $22.62 | $0.00 |
DisclosureSEC source: 0001935979-25-000045 · wk-form4_1746652465.xml · derivative · entry 1 Bailey Gregory · CIK 0001329505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,716 Underlying: Common Shares · 31,716 shares Expires 2035-05-05 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| May 05, 2025 Filed May 7, 2025 21:13 UTC |
Mehta KishanDirector
|
GrantStock Options (Right to buy) · Derivative | 31,716 | $0.00 Strike: $22.62 | $0.00 |
DisclosureSEC source: 0001935979-25-000044 · wk-form4_1746652427.xml · derivative · entry 1 Mehta Kishan · CIK 0001850520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,716 Underlying: Common Shares · 31,716 shares Expires 2035-05-05 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| May 05, 2025 Filed May 7, 2025 21:13 UTC |
GREGORY JULIA PDirector
|
GrantStock Options (Right to buy) · Derivative | 31,716 | $0.00 Strike: $22.62 | $0.00 |
DisclosureSEC source: 0001935979-25-000043 · wk-form4_1746652387.xml · derivative · entry 1 GREGORY JULIA P · CIK 0001226675 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,716 Underlying: Common Shares · 31,716 shares Expires 2035-05-05 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| May 05, 2025 Filed May 7, 2025 21:11 UTC |
HUGIN ROBERT JDirector
|
GrantStock Options (Right to buy) · Derivative | 31,716 | $0.00 Strike: $22.62 | $0.00 |
DisclosureSEC source: 0001935979-25-000041 · wk-form4_1746652311.xml · derivative · entry 1 HUGIN ROBERT J · CIK 0001232505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,716 Underlying: Common Shares · 31,716 shares Expires 2035-05-05 F1 · derivative.exercise_date: The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 12:01 UTC |
CHILDS JOHN WDirector
|
PurchaseCommon Shares | 900 | $30.73 | $27,653.49 |
DisclosureSEC source: 0001935979-25-000018 · wk-form4_1741176105.xml · nonDerivative · entry 4 CHILDS JOHN W · CIK 0001027035 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By 1994 Charitable Remainder Trust Disclosed balance after: 25,291 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.54 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 12:01 UTC |
CHILDS JOHN WDirector
|
PurchaseCommon Shares | 3,400 | $30.73 | $104,468.74 |
DisclosureSEC source: 0001935979-25-000018 · wk-form4_1741176105.xml · nonDerivative · entry 3 CHILDS JOHN W · CIK 0001027035 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By 2013 Charitable Remainder Trust Disclosed balance after: 76,570 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.54 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 12:01 UTC |
CHILDS JOHN WDirector
|
PurchaseCommon Shares | 3,400 | $30.73 | $104,468.74 |
DisclosureSEC source: 0001935979-25-000018 · wk-form4_1741176105.xml · nonDerivative · entry 2 CHILDS JOHN W · CIK 0001027035 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By 2007 Charitable Remainder Trust Disclosed balance after: 24,452 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.54 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 12:01 UTC |
CHILDS JOHN WDirector
|
PurchaseCommon Shares | 25,000 | $30.39 | $759,647.50 |
DisclosureSEC source: 0001935979-25-000018 · wk-form4_1741176105.xml · nonDerivative · entry 1 CHILDS JOHN W · CIK 0001027035 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By John W Childs 2013 Revocable Trust Disclosed balance after: 2,320,571 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 04, 2025 Filed Mar 9, 2026 22:12 UTC Amendment |
CHILDS JOHN WDirector
|
PurchaseCommon Shares | 28,400 | $30.43 | $864,115.44 |
DisclosureSEC source: 0001027035-26-000006 · wk-form4a_1773094322.xml · nonDerivative · entry 1 CHILDS JOHN W · CIK 0001027035 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By John W Childs 2013 Revocable Trust Disclosed balance after: 2,323,971 F1 · shares: This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on March 5, 2025 (the "Original Form 4"). The Original Form 4 inadvertently misstated that 3,400 Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust, and 25,000 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust. However, as reflected in this amendment, 28,400 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust, and no Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. F2 · balance_after: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| January 05, 2025 Filed Jan 7, 2025 20:49 UTC |
Buten MatthewChief Financial Officer
|
Exercise / conversionRestricted Share Unit Award · Derivative | 4,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001935979-25-000003 · wk-form4_1736300950.xml · derivative · entry 5 Buten Matthew · CIK 0001898799 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,750 Underlying: Common Shares · 4,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F4 · price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F5 · derivative.exercise_date: The reporting person was granted 17,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date. F6 · derivative.expiration_date: Not applicable. Read SEC document |
| January 05, 2025 Filed Jan 7, 2025 20:49 UTC |
Buten MatthewChief Financial Officer
|
GrantRestricted Share Unit Award · Derivative | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001935979-25-000003 · wk-form4_1736300950.xml · derivative · entry 4 Buten Matthew · CIK 0001898799 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Shares · 17,000 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F4 · price: Each restricted share unit represents the contingent right to receive one common share of the Issuer. F5 · derivative.exercise_date: The reporting person was granted 17,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date. F6 · derivative.expiration_date: Not applicable. Read SEC document |
| January 05, 2025 Filed Jan 7, 2025 20:49 UTC |
Buten MatthewChief Financial Officer
|
GrantStock Options (Right to buy) · Derivative | 104,000 | $0.00 Strike: $38.64 | $0.00 |
DisclosureSEC source: 0001935979-25-000003 · wk-form4_1736300950.xml · derivative · entry 3 Buten Matthew · CIK 0001898799 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,000 Underlying: Common Shares · 104,000 shares Expires 2035-01-05 F3 · derivative.exercise_date: The shares underlying this option vest in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service with the Issuer at each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.